TY  - JOUR
AU  - Gallego-Duran, Rocio
AU  - Montero-Vallejo, Rocio
AU  - Maya-Miles, Douglas
AU  - Lucena, Ana
AU  - Martin, Franz
AU  - Ampuero, Javier
AU  - Romero-Gomez, Manuel
PY  - 2021
DO  - 10.3389/fimmu.2021.667354
UR  - https://hdl.handle.net/10668/28371
T2  - Frontiers in immunology
AB  - Metabolic associated fatty liver disease (MAFLD) is the most prevalent form of liver disease worldwide, accounting for a high liver-related mortality and morbidity with extensive multi-organ involvement. This entity has displaced viral hepatitis as...
LA  - en
PB  - Frontiers Research Foundation
KW  - NAFLD
KW  - NASH
KW  - biomarkers
KW  - fibrosis
KW  - immunology
KW  - Animals
KW  - Humans
KW  - Non-alcoholic Fatty Liver Disease
TI  - Analysis of Common Pathways and Markers From Non-Alcoholic Fatty Liver Disease to Immune-Mediated Diseases.
TY  - research article
VL  - 12
ER  -